中国 EN 400-660-9091

联系我们

电话:025-68037686

地址:江苏生命科技创新园F6幢1层

订购:nanjing03@biogot.com

服务:biorase01@biogot.com

合作:lvyun@biogot.com

支持:may@biogot.com

Bioworld引用文献(23852),当前文献数据更新至2024年12月31日

  • Downregulation of GBAS regulates oral squamous cell carcinoma proliferation and apoptosis via the p53 signaling pathway
    Journal: OncoTargets and Therapy 引用产品:Rhodamine-conjugated secondary antibodies()
    ApplicationIHC
    IF3.046
    SpeciesHuman
  • CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression
    Journal: OncoTargets and Therapy 引用产品:pLenti-CMV-hMGMT plasmid()
    Application
    IF3.046
    Species
  • Transcobalamin I: a novel prognostic biomarker of neoadjuvant chemotherapy in locally advanced hypopharyngeal squamous cell cancers
    Journal: OncoTargets and Therapy 引用产品:anti-PARP antibody(BS7190)
    ApplicationWB
    IF3.046
    SpeciesHuman
  • Transcobalamin I: a novel prognostic biomarker of neoadjuvant chemotherapy in locally advanced hypopharyngeal squamous cell cancers
    Journal: OncoTargets and Therapy 引用产品:anti-cleaved-caspase 3 antibody(BS7004)
    ApplicationWB
    IF3.046
    SpeciesHuman
  • Transcobalamin I: a novel prognostic biomarker of neoadjuvant chemotherapy in locally advanced hypopharyngeal squamous cell cancers
    Journal: OncoTargets and Therapy 引用产品:anti-GAPDH antibody(AP0063/MB001)
    ApplicationWB
    IF3.046
    SpeciesHuman
  • Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway
    Journal: OncoTargets and Therapy 引用产品:anti-VEGFa antibody(BS6496)
    ApplicationWB
    IF3.046
    SpeciesHuman
  • Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway
    Journal: OncoTargets and Therapy 引用产品:anti-c-Myc antibody(BS4126)
    ApplicationWB
    IF3.046
    SpeciesHuman
  • Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer
    Journal: OncoTargets and Therapy 引用产品:anti-OPN primary antibody(BS1264)
    ApplicationIHC,WB
    IF3.046
    SpeciesHuman
  • Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer
    Journal: OncoTargets and Therapy 引用产品:anti-LDHA antibody()
    ApplicationWB
    IF3.046
    SpeciesHuman
  • Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer
    Journal: OncoTargets and Therapy 引用产品:anti-β-actin antibody(AP0060/BS6007M)
    ApplicationWB
    IF3.046
    SpeciesHuman

关注我们

400-660-9091

电话:025-68037686

地址:江苏生命科技创新园F6幢1层

订购:nanjing03@biogot.com

服务:biorase01@biogot.com

合作:lvyun@biogot.com

支持:may@biogot.com